SlideShare uma empresa Scribd logo
1 de 8
eCOA and ePRO
and Their Use In
Clinical Trials
PRESENTER:
Soumya pottola
soumyapottola19@gmail.com |https://clinicalda.blogspot.com | +1 (972) 891-9506
PRO(Patient Reported Outcomes) and
ePRO(electronic Patient Reported
Outcomes)
Electronic patient-reported outcomes (ePRO) in a
clinical trial allow patients to answer questions and
report on their health through an electronic device,
such as a smartphone or tablet.
Using ePRO in a clinical trial starts with trial design.
A study team will decide what feedback they want
from patients, and the best format to capture that
information, whether through an app, e-patient
diary, or other form. Patients may use devices
provided by the trial, or install an app on their own
device.
Various measures by Pro
There are different types of ePROs such as:
● Electronic questionnaires that periodically assess patients’ health status at
predetermined times set by the clinical trial protocol on tablets, computers, and
mobile devices
● Patient diaries or activity logs that involve data entry by the patient at any time
convenient to them which can help detect safety issues as soon as they occur
● Fitness and health trackers that automatically record data without any
intervention from the patient
● Ecological momentary assessment (EMA) that assesses a patient’s experiences,
behaviors, and moods as they occur in real-time
Electronic patient-reported outcome (ePRO) measures allow data to be entered directly by patients in an
electronic format. Like other eCOAs, ePROs also have certain distinct advantages over traditional PRO
measures such as:
● Real-time data capture which is particularly important in case of pain symptoms and safety events
that require immediate attention
● Better patient adherence because of easy-to-fill questionnaires that allow for data entry at the
time of occurrence
● Improved patient convenience as data can be collected from technologies such as smartwatches
and is transmitted directly to research teams without any change in the patient’s daily activities
COA(Clinical outcome assessments)and
eCOA(electronic Clinical outcome
assessments)
The United States Food and Drug
Administration (FDA) defines a clinical
outcome assessment (COA) as a
measure that describes or reflects how a
patient feels, functions, or survives.
There are various types of COAs
depending upon the person reporting
the patients’ symptoms, but the
fundamental focus is on patient health
status
Types of Clinical Outcome Assessment (COA)
The various types of COAs are as follows:
● Patient-reported outcome (PRO) measure:
measurement based on a report comes directly from the patient/study subject about the status of the patient’s health condition
without any amendment or interpretation by a clinician or anyone else.
● Observer-reported outcome (ObsRO) measure:
measurement based on a report of observable signs, events, or behaviors related to a patient’s health condition by someone
other than the patient or health professional such as a parent, caregiver, or someone who observes the patient in daily life.
● Clinician-reported outcome (ClinRO) measure:
measurement based on a report that comes from a trained healthcare professional after observation of a patient’s health
condition through interpretation of observable signs, behaviors or other manifestations related to the disease or condition.
Difference between ePRO and eCOA

Mais conteúdo relacionado

Semelhante a eCOA and ePRO and their use in Clinical trials

Mu Stage1 Req Overview
Mu Stage1 Req OverviewMu Stage1 Req Overview
Mu Stage1 Req Overview
csheets2
 
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docxSWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
mabelf3
 
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docxSWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
deanmtaylor1545
 
Building a consensus for the electronic health record
Building a consensus for the electronic health recordBuilding a consensus for the electronic health record
Building a consensus for the electronic health record
Nursing353
 
Building a consensus for the electronic health record
Building a consensus for the electronic health recordBuilding a consensus for the electronic health record
Building a consensus for the electronic health record
tschenf
 
Building a consensus for the electronic health record
Building a consensus for the electronic health recordBuilding a consensus for the electronic health record
Building a consensus for the electronic health record
tschenf
 
Building a consensus for the electronic health record
Building a consensus for the electronic health recordBuilding a consensus for the electronic health record
Building a consensus for the electronic health record
Nursing353
 

Semelhante a eCOA and ePRO and their use in Clinical trials (20)

Mu Stage1 Req Overview
Mu Stage1 Req OverviewMu Stage1 Req Overview
Mu Stage1 Req Overview
 
Eng-full corporate profile v2 2017
Eng-full corporate profile v2 2017Eng-full corporate profile v2 2017
Eng-full corporate profile v2 2017
 
Comparative Effectiveness
Comparative EffectivenessComparative Effectiveness
Comparative Effectiveness
 
Three Examples of Success in Personal Internet Support and Telecare
Three Examples of Success in Personal Internet Support and TelecareThree Examples of Success in Personal Internet Support and Telecare
Three Examples of Success in Personal Internet Support and Telecare
 
Defining the Evidence for Personal Connected Health
Defining the Evidence for Personal Connected HealthDefining the Evidence for Personal Connected Health
Defining the Evidence for Personal Connected Health
 
Timely Use of Medication History in Electronic Health Record Software.pdf
Timely Use of Medication History in Electronic Health Record Software.pdfTimely Use of Medication History in Electronic Health Record Software.pdf
Timely Use of Medication History in Electronic Health Record Software.pdf
 
D1 Clinical Process 2223 (1).pptx
D1 Clinical Process 2223 (1).pptxD1 Clinical Process 2223 (1).pptx
D1 Clinical Process 2223 (1).pptx
 
Safety_Data_Reconciliation_Katalyst HLS
Safety_Data_Reconciliation_Katalyst HLSSafety_Data_Reconciliation_Katalyst HLS
Safety_Data_Reconciliation_Katalyst HLS
 
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docxSWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
 
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docxSWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
SWP PHARMACEUTICALS, INC. - DATA MANAGEMENT PLANA Prospective,.docx
 
Patient generated-data
Patient generated-dataPatient generated-data
Patient generated-data
 
Health IT Summit Atlanta 2014 - Keynote Presentation "Big Data, Value Analysi...
Health IT Summit Atlanta 2014 - Keynote Presentation "Big Data, Value Analysi...Health IT Summit Atlanta 2014 - Keynote Presentation "Big Data, Value Analysi...
Health IT Summit Atlanta 2014 - Keynote Presentation "Big Data, Value Analysi...
 
Patient Scoring tools, Material Safety Data Sheet, Antibiotic Policy and Anti...
Patient Scoring tools, Material Safety Data Sheet, Antibiotic Policy and Anti...Patient Scoring tools, Material Safety Data Sheet, Antibiotic Policy and Anti...
Patient Scoring tools, Material Safety Data Sheet, Antibiotic Policy and Anti...
 
Remote Patient Monitoring
Remote Patient MonitoringRemote Patient Monitoring
Remote Patient Monitoring
 
Building a consensus for the electronic health record
Building a consensus for the electronic health recordBuilding a consensus for the electronic health record
Building a consensus for the electronic health record
 
Building a consensus for the electronic health record
Building a consensus for the electronic health recordBuilding a consensus for the electronic health record
Building a consensus for the electronic health record
 
Building a consensus for the electronic health record
Building a consensus for the electronic health recordBuilding a consensus for the electronic health record
Building a consensus for the electronic health record
 
Building a consensus for the electronic health record
Building a consensus for the electronic health recordBuilding a consensus for the electronic health record
Building a consensus for the electronic health record
 
zinullah presentation.pdf
zinullah presentation.pdfzinullah presentation.pdf
zinullah presentation.pdf
 
Kaiku - Patient-reported outcomes and the future of data-driven cancer care. ...
Kaiku - Patient-reported outcomes and the future of data-driven cancer care. ...Kaiku - Patient-reported outcomes and the future of data-driven cancer care. ...
Kaiku - Patient-reported outcomes and the future of data-driven cancer care. ...
 

Último

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 

Último (20)

How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 

eCOA and ePRO and their use in Clinical trials

  • 1. eCOA and ePRO and Their Use In Clinical Trials PRESENTER: Soumya pottola soumyapottola19@gmail.com |https://clinicalda.blogspot.com | +1 (972) 891-9506
  • 2. PRO(Patient Reported Outcomes) and ePRO(electronic Patient Reported Outcomes) Electronic patient-reported outcomes (ePRO) in a clinical trial allow patients to answer questions and report on their health through an electronic device, such as a smartphone or tablet. Using ePRO in a clinical trial starts with trial design. A study team will decide what feedback they want from patients, and the best format to capture that information, whether through an app, e-patient diary, or other form. Patients may use devices provided by the trial, or install an app on their own device.
  • 4. There are different types of ePROs such as: ● Electronic questionnaires that periodically assess patients’ health status at predetermined times set by the clinical trial protocol on tablets, computers, and mobile devices ● Patient diaries or activity logs that involve data entry by the patient at any time convenient to them which can help detect safety issues as soon as they occur ● Fitness and health trackers that automatically record data without any intervention from the patient ● Ecological momentary assessment (EMA) that assesses a patient’s experiences, behaviors, and moods as they occur in real-time Electronic patient-reported outcome (ePRO) measures allow data to be entered directly by patients in an electronic format. Like other eCOAs, ePROs also have certain distinct advantages over traditional PRO measures such as: ● Real-time data capture which is particularly important in case of pain symptoms and safety events that require immediate attention ● Better patient adherence because of easy-to-fill questionnaires that allow for data entry at the time of occurrence ● Improved patient convenience as data can be collected from technologies such as smartwatches and is transmitted directly to research teams without any change in the patient’s daily activities
  • 5. COA(Clinical outcome assessments)and eCOA(electronic Clinical outcome assessments) The United States Food and Drug Administration (FDA) defines a clinical outcome assessment (COA) as a measure that describes or reflects how a patient feels, functions, or survives. There are various types of COAs depending upon the person reporting the patients’ symptoms, but the fundamental focus is on patient health status
  • 6. Types of Clinical Outcome Assessment (COA)
  • 7. The various types of COAs are as follows: ● Patient-reported outcome (PRO) measure: measurement based on a report comes directly from the patient/study subject about the status of the patient’s health condition without any amendment or interpretation by a clinician or anyone else. ● Observer-reported outcome (ObsRO) measure: measurement based on a report of observable signs, events, or behaviors related to a patient’s health condition by someone other than the patient or health professional such as a parent, caregiver, or someone who observes the patient in daily life. ● Clinician-reported outcome (ClinRO) measure: measurement based on a report that comes from a trained healthcare professional after observation of a patient’s health condition through interpretation of observable signs, behaviors or other manifestations related to the disease or condition.